We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

WHO Advises Against Using Fluvoxamine and Colchicine for COVID-19

July 18, 2022
The WHO did not make any recommendation on the use of the drugs for severe and critical cases of COVID-19. Read More

EU Flags Severe Allergic Reaction Risk to Novavax’s COVID-19 Vaccine

July 18, 2022
Conditionally authorized in the EU since December 2021, the vaccine received emergency use authorization from the FDA on July 13. Read More

Watmind USA COVID-19 Test Gets Emergency Use Authorization

July 18, 2022
The FDA said confirmation with a molecular assay may be necessary. Read More

FDA Authorizes Novavax’s COVID-19 Vaccine

July 14, 2022
The FDA has granted Emergency Use Authorization (EUA) to Novavax’s COVID-19 vaccine. Read More

Alnylam Sues Pfizer, BioNTech and Moderna Again Over Alleged Patent Infringement

July 14, 2022
This isn’t the first time the companies have been accused of patent infringement with regard to their COVID-19 vaccines. Read More

FDA Grants Approval to Pfizer-BioNTech COVID-19 Vaccine for Children 12 to 15 Years Old

July 12, 2022
The vaccine received Emergency Use Authorization for this specific pediatric population in May 2021. Read More

CureVac Goes After BioNTech Claiming Patent Infringement by Comirnaty’s mRNA Underpinnings

July 7, 2022
CureVac has filed a patent infringement lawsuit against BioNTech, claiming its messenger RNA (mRNA) technology was used without credit or compensation to create BioNTech’s and Pfizer’s Comirnaty, the world’s first approved COVID-19 vaccine and now the most widely used one. Read More

FDA Revises EUA to Allow Pharmacists to Prescribe Pfizer’s Paxlovid

July 7, 2022
The FDA has revised the Emergency Use Authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir and ritonavir) to allow state-licensed pharmacists to prescribe the oral antiviral drug to COVID-19 patients. Read More

Canada to Toss 13.6 Million Expired AstraZeneca COVID-19 Vaccines

July 7, 2022
Only 2.3 million Canadians had received at least one dose of this specific vaccine. Read More

AstraZeneca’s Evusheld and Regeneron’s REGEN-COV Shelf Life Extended

July 5, 2022
REGEN-COV doses are being stored for possible use against future COVID-19 variants. Read More

FDA Recommends Modified COVID-19 Vaccine Boosters Adapted to Omicron BA.4 and BA.5 Subvariants

July 5, 2022
No studies have been conducted yet on modified vaccines containing an Omicron BA.4/5 component. Read More

Innova Medical Group Earns CE Mark for Its Rapid Antigen Self-Test for COVID-19

July 5, 2022
Innova’s rapid antigen self-test detects multiple proteins in the SARS-CoV-2 virus. Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 … 174 175 Next

Upcoming Events

  • 28Sep

    The Cost of Counterfeiting: Why You Need a Plan to Secure Your Medical Device Supply Chain

  • 28Sep

    Calculating Sample Size to Satisfy FDA Expectations

  • 11Oct

    GMP Quality Management vSummit 2023: Where Quality Meets Risk

  • 16Oct

    MAGI@home Clinical Research Conference 2023

  • 26Oct

    FDA in 2024: What to Expect in an Election Year

  • 08Nov

    18th Annual FDA Inspections vSummit

Featured Products

  • FDA, FTC and DOJ Enforcement of Medical Device Regulations

    FDA, FTC and DOJ Enforcement of Medical Device Regulations

  • Using Real-World Evidence in Drug and Device Submissions

    Using Real-World Evidence in Drug and Device Submissions

Featured Stories

  • Culture of Quality and Compliance Go Hand in Hand, Says Expert

  • First-in-Human Studies of Artificial Wombs Subject of FDA’s Adcomm This Week

  • BCBS of Louisiana Sues Celgene, BMS for Patent Fraud of Blockbuster Drug Pomalyst

  • AI/ML Data Collection Needs to Avoid Bias, FDA Dep. Director Says

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing